GARY STRONG: Open Payments
NPI 1679643563 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,163 in 152 payments from 16 companies in 2025. Trend: 2023 $1,821 · 2024 $1,723 · 2025 $2,163
Food & beverage: $2,088Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 51 | $548 |
| ABBVIE INC. | 22 | $265 |
| UCB, Inc. | 19 | $243 |
| Regeneron Healthcare Solutions, Inc. | 11 | $168 |
| Lilly USA, LLC | 7 | $167 |
| Organon LLC | 13 | $166 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $101 |
| E.R. Squibb & Sons, L.L.C. | 6 | $96 |
| BioWound Solutions, Inc. | 7 | $85 |
Products named: TREMFYA, RINVOQ, Bimzelx, DUPIXENT, TALTZ, SPEVIGO, Sotyktu, LIBTAYO.
Industry payments across WA — which companies pay providers there.
